Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership

IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Toro Neurovascular, a company pioneering advanced catheter technologies for neurovascular intervention, today announced an exclusive distribution partnership with Kaneka Medical America for Toro’s novel neurovascular catheter portfolio in the U.S. market, pending regulatory clearance.

“Partnering with Kaneka accelerates our mission to equip physicians with tools that make the most challenging neurovascular procedures more predictable and controlled,” said Hyung Posalit, CEO of Toro Neurovascular. “Kaneka’s strong commercial infrastructure and shared commitment to clinical excellence make them an ideal partner to bring our technology to market swiftly and at scale.”

The collaboration will bring Toro’s next-generation catheter platform—engineered for superior trackability, distal support, and stability during complex interventions—to clinicians treating ischemic and hemorrhagic stroke across the United States. Toro’s novel catheter platform is designed to address unmet clinical needs with a focus on performance, deliverability, and versatility across a wide range of neurovascular interventions.

“Toro’s catheter technologies complement and strengthen our existing neurovascular portfolio, giving us the opportunity to offer a broader spectrum of solutions to patients suffering from neurovascular disease,” said Ken Toda, President of Kaneka Medical America. “Together, we aim to deliver innovations that help improve procedural precision and patient care.”

Rob Abrams, Chief Strategy Officer for Kaneka Medical America added, “Our partnership with Toro reflects Kaneka’s culture of innovation and shared commitment to lasting impact in neurovascular care.”

To strengthen its commercialization efforts, Toro has appointed Marc Paris as Chief Commercial Officer. Paris brings more than two decades of leadership in medical device commercialization and will oversee market launch strategy in collaboration with Kaneka.

“Joining Toro Neurovascular at this exciting time, especially with our partnership with Kaneka, is a tremendous opportunity,” said Paris. “Toro’s engineering team has developed a technology that truly advances the standard of neurovascular catheter design.”

About Toro Neurovascular

Toro Neurovascular develops high-performance technologies for the treatment of neurovascular disease. Headquartered in Irvine, California, the company combines clinical insight and advanced engineering to enhance patient outcomes worldwide.
Learn more: www.toroneuro.com

About Kaneka

Kaneka Corporation is a global leader in healthcare innovation, with an expanding neurovascular presence. Through its commitment to scientific advancement and strategic partnerships, Kaneka aims to provide life-saving medical technologies that improve patient care and quality of life.

Media Contact

info@toroneuro.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/aff55aa4-c651-4b25-92ef-828e30edb559


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.